acetylcysteine
NDC 0574-0805, Acetylcysteine, injection, from Padagis US LLC.
- Product NDC
- 0574-0805
- Status
- Listed
- Labeler
- Padagis US LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA021539
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0574-0805 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACETYLCYSTEINE200 mg/mL
Pharmacologic classes
Antidote [EPC]; Antidote for Acetaminophen Overdose [EPC]; Decreased Respiratory Secretion Viscosity [PE]; Increased Glutathione Concentration [PE]; Mucolytic [EPC]; Reduction Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0574-0805-30 | 00574080530 | 4 VIAL in 1 CARTON (0574-0805-30) / 30 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9d305722-e74f-4f48-8d2c-0daa99144749Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0574-0805
Use it
Look up 0574-0805 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0574-0805 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0574-0805. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.